Laura Benjamin
Directeur/Bestuurslid bij ALLARITY THERAPEUTICS, INC.
Actieve functies van Laura Benjamin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Directeur/Bestuurslid | - | - |
| Independent Dir/Board Member | - | - | |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Directeur/Bestuurslid | 01-01-2018 | - |
| Algemeen Directeur | 01-01-2018 | - | |
| Oprichter | 01-01-2018 | - | |
| President | 01-01-2018 | - | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Directeur/Bestuurslid | - | - |
| Independent Dir/Board Member | - | - |
Loopbaan van Laura Benjamin
Opleiding van Laura Benjamin
| University of Pennsylvania | Doctorate Degree |
| Barnard College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Denemarken | 2 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Beurs
- Insiders
- Laura Benjamin
- Ervaring
